Cargando…

Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography

The use of (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) for response assessment in lymphoma is now widespread. Prognostic information obtained from PET performed after two to three cycles of chemotherapy may guide more individualized, risk-adapted therapeutic strategies. Progress...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kasamon, Yvette L.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021845/ https://www.ncbi.nlm.nih.gov/pubmed/21253532 http://dx.doi.org/10.1155/2011/271595

Ejemplares similares

The prognostic value of 18-FDG positron emission tomography in T cell non-Hodgkin lymphoma
por: Eslick, R, et al.
Publicado: (2017)

Bleomycin-Induced Lung Toxicity in Hodgkin's Lymphoma: Risk Factors in the Positron Emission Tomography Era
por: Jennane, Selim, et al.
Publicado: (2022)

18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell Lymphoma
por: Shelly, M. J., et al.
Publicado: (2012)

The role of fluorodeoxyglucose positron emission tomography-computerized tomography in resolving therapeutic dilemmas in pediatric Hodgkin lymphoma
por: Seth, Rachna, et al.
Publicado: (2012)

The Correlation Between Pre-treatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters and Clinical Prognostic Factors in Pediatric Hodgkin Lymphoma
por: Tatcı, Ebru, et al.
Publicado: (2017)

Outcomes and relapse patterns following chemotherapy in advanced Hodgkin lymphoma in the positron emission tomography era
por: Lapuz, Carminia, et al.
Publicado: (2018)

Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin’s lymphoma
por: Kim, Yu Ri, et al.
Publicado: (2021)

Positron emission tomography/computed tomography in the diagnosis, staging, and prognostic evaluation of natural killer/T-cell lymphoma
por: Ding, Jian-Jun, et al.
Publicado: (2018)

Association Between Ownership of Imaging Equipment and Appropriateness of Staging Positron-Emission Tomography in Non-Hodgkin Lymphoma
por: Huntington, Scott F, et al.
Publicado: (2019)

Observations of Oncologists on Treatment Selection With Interim Positron Emission Tomography–Adapted Approaches in Classic Hodgkin Lymphoma: The Real-World CONNECT Study
por: Parsons, Susan K., et al.
Publicado: (2023)

Promising Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Human Immunodeficiency Virus Associated Non-Hodgkin's Lymphoma
por: Kung, Boom Ting, et al.
Publicado: (2015)

Paraneoplastic syndrome turned out to be non-Hodgkin's lymphoma on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography
por: Sahoo, Manas Kumar, et al.
Publicado: (2016)

Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Hodgkin's Lymphoma: Diagnostic Challenge during COVID Vaccination
por: Usmani, Sharjeel, et al.
Publicado: (2021)

Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Hodgkin's Lymphoma, COVID Vaccination, and Appropriate Investigation Time
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Fluorodeoxyglucose-positron emission tomography staging can replace bone marrow biopsy in Hodgkin's lymphoma. Results from Brazilian Hodgkin's Lymphoma Study Group
por: Cerci, Juliano Júlio, et al.
Publicado: (2018)

FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma
por: Kasamon, Yvette L., et al.
Publicado: (2017)

Neurolymphomatosis – Rare presentation in non-Hodgkin’s lymphoma: The role of (18)F-fluorodeoxyglucose positron-emission tomography and computerized tomography imaging
por: Fatima, Nosheen, et al.
Publicado: (2020)

Relationship between semiquantitative (18)F-fluorodeoxyglucose positron emission tomography metrics and necrosis in classical Hodgkin lymphoma
por: Kahle, X. U., et al.
Publicado: (2019)

Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin’s or Non-Hodgkin’s Lymphoma?
por: Çetin, Güven, et al.
Publicado: (2015)

Positron Emission Tomography
por: Piepmeier, Joseph M.
Publicado: (1986)

Role of Positron Emission Tomography in Primary Central Nervous System Lymphoma
por: Rozenblum, Laura, et al.
Publicado: (2022)

Detectors in positron emission tomography
por: Zatcepin, Artem, et al.
Publicado: (2022)

18 Fluoride-fluorodeoxyglucose positron emission tomography in initial staging and response assessment of primary non-Hodgkin lymphoma of the tibia
por: Harisankar, Chidambaram Natrajan Balasubramanian, et al.
Publicado: (2014)

Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography–Directed Therapy for Early-Stage Hodgkin Lymphoma
por: Cutter, David J., et al.
Publicado: (2021)

Positron emission tomography: An overview
por: Shukla, A. K., et al.
Publicado: (2006)

Radiochemistry for positron emission tomography
por: Rong, Jian, et al.
Publicado: (2023)

Malaria masquerading as relapse of Hodgkin's lymphoma on contrast enhanced (18)F-fluorodeoxyglucose positron emission tomography/computed tomography: A diagnostic dilemma
por: Jeph, Sunil, et al.
Publicado: (2014)

Isolated Splenic Tuberculosis Masquerading as Disease Progression of Hodgkin's Lymphoma on Interim(18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scan
por: Dey, Sudip, et al.
Publicado: (2021)

Utility of F-18 Fluorodeoxyglucose Positron Emission Tomography - Computed Tomography in Primary Thyroid Lymphoma
por: Singh, Vijay, et al.
Publicado: (2022)

Hypermetabolic lymphadenopathy on positron emission tomography scan following COVID‐19 vaccination: A mimicker of disease progression in Hodgkin lymphoma
por: Suleman, Adam, et al.
Publicado: (2021)

Use of (18)F-fludeoxyglucose positron emission tomography-CT in the management of breast implant-associated anaplastic large cell lymphoma
por: Ladani, Sapna, et al.
Publicado: (2016)

Positron Emission Tomography Imaging of Atherosclerosis
por: Orbay, Hakan, et al.
Publicado: (2013)

Positron Emission Tomography in Breast Cancer
por: Vercher-Conejero, Jose Luis, et al.
Publicado: (2015)

Positron Emission Tomography (PET) in Oncology
por: Gallamini, Andrea, et al.
Publicado: (2014)

Sensors for Positron Emission Tomography Applications
por: Jiang, Wei, et al.
Publicado: (2019)

Imaging Inflammation with Positron Emission Tomography
por: Iking, Janette, et al.
Publicado: (2021)

Accuracy of Positron Emission Tomography-Computed Tomography in Bone Marrow Involvement Lymphoma
por: Çekdemir, Demet, et al.
Publicado: (2015)

Nodular fasciitis mimicking recurrent lymphoma on positron emission tomography–computed tomography
por: Zhou, Qiao, et al.
Publicado: (2016)

Positron emission tomography-computed tomography in subcutaneous panniculitis-like T-cell lymphoma
por: Bikkina, Prathyusha, et al.
Publicado: (2019)

Utero-Ovarian Involvement in Non-Hodgkin's Lymphoma on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: A Case Series and Literature Review
por: Saini, Vivek Kumar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_agfuili83b50i8vbfuluc68cn5